On March 18, 2019 IntelGenx Technologies Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) reported that it will release its fourth quarter and full year 2018 financial results after market close on March 22, 2019 (Press release, IntelGenx, MAR 18, 2019, View Source;Conference-Call-to-Follow-on-March-25-2019/default.aspx [SID1234534437]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

An associated conference call will be hosted by Dr. Horst G. Zerbe, President and Chief Executive Officer, and Mr. Andre Godin, Executive Vice-President and Chief Financial Officer, on March 25, 2019 to discuss the results and provide a business update. Details of the conference call and webcast are below:

Date: Monday, March 25, 2019

Time: 8:00 a.m. EDT

Conference dial-in: (833) 231-8269

International dial-in: (647) 689-4114

Conference ID: 1297963

Webcast Registration: Click here

Following the live call, a replay will be available on the Company’s website, www.intelgenx.com, under "Investor Relations".